BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28976720)

  • 1. Infliximab-induced acne and acute localized exanthematous pustulosis: Case report.
    Senilă S; Seicean A; Fechete O; Grad A; Ungureanu L
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28976720
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute generalized exanthematous pustulosis due to terbinafine.
    Ross CL; Shevchenko A; Mollanazar NK; Hsu S; Motaparthi K
    Dermatol Ther; 2018 Jul; 31(4):e12617. PubMed ID: 29786933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19.
    Enos T; Jeong HS; Vandergriff T; Jacobe HT; Chong BF
    Dermatol Ther; 2020 Nov; 33(6):e13834. PubMed ID: 32542893
    [No Abstract]   [Full Text] [Related]  

  • 4. Case of psoriasiform and pustular eruptions in addition to alopecia as a paradoxical reaction induced by infliximab.
    Shimokata M; Namiki T; Tokoro S; Ugajin T; Miura K; Yokozeki H
    J Dermatol; 2018 Dec; 45(12):e331-e333. PubMed ID: 29855072
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute Generalized Exanthematous Pustulosis Caused by Faropenem: A Possible Pathogenetic Role for Interleukin-23.
    Sakuragi Y; Sawada Y; Hara Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Nakamura M
    Acta Derm Venereol; 2016 Feb; 96(2):265-6. PubMed ID: 26302837
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute generalized exanthematous pustulosis induced by a digestive enzyme drug, Festal
    Lee SK; Kim MS; Lee UH
    Clin Exp Dermatol; 2018 Apr; 43(3):321-323. PubMed ID: 29341242
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute generalized exanthematous pustulosis due to benznidazole.
    Álava-Cruz C; Rojas Perez-Ezquerra P; Pelta-Fernández R; Zubeldia-Ortuño JM; de Barrio-Fernández M
    J Allergy Clin Immunol Pract; 2014; 2(6):800-2. PubMed ID: 25439377
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute generalized exanthematous pustulosis induced by hydroxychloroquine successfully treated with etretinate.
    Matsuda-Hirose H; Sho Y; Yamate T; Nakamura Y; Saito K; Takeo N; Nishida H; Ishii K; Sugiura K; Hatano Y
    J Dermatol; 2020 Feb; 47(2):e53-e54. PubMed ID: 31840277
    [No Abstract]   [Full Text] [Related]  

  • 9. First-dose anaphylaxis to infliximab: a case of mammalian meat allergy.
    Chitnavis M; Stein DJ; Commins S; Schuyler AJ; Behm B
    J Allergy Clin Immunol Pract; 2017; 5(5):1425-1426. PubMed ID: 28634101
    [No Abstract]   [Full Text] [Related]  

  • 10. Infliximab-induced acne: report of a third case.
    Sladden MJ; Clarke PJ; Mitchell B
    Br J Dermatol; 2008 Jan; 158(1):172. PubMed ID: 17854357
    [No Abstract]   [Full Text] [Related]  

  • 11. Infliximab-induced acne: report of two cases.
    Bassi E; Poli F; Charachon A; Claudepierre P; Revuz J
    Br J Dermatol; 2007 Feb; 156(2):402-3. PubMed ID: 17223901
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment with infliximab or azathioprine negatively impact the efficacy of hepatitis B vaccine in inflammatory bowel disease patients.
    Andrade P; Santos-Antunes J; Rodrigues S; Lopes S; Macedo G
    J Gastroenterol Hepatol; 2015 Nov; 30(11):1591-5. PubMed ID: 25967740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pustular drug hypersensitivity syndrome due to allopurinol.
    Ben Salem C; Saidi W; Larif S; Fathallah N; Slim R; Hmouda H
    Indian J Pharmacol; 2015; 47(1):123-4. PubMed ID: 25821326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Rescue Therapy in Crohn's Patients Maintained on Infliximab After Withdrawal of the Immunomodulator: A Long-Term Follow-Up.
    Fischer M; Campbell SC; Calley CSJ; Helper DJ; Chiorean MV; Fadda HM
    Dig Dis Sci; 2017 Nov; 62(11):3131-3137. PubMed ID: 28986660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Localized Exanthematous Pustulosis Due to Bemiparin.
    Gómez Torrijos E; Cortina de la Calle MP; Méndez Díaz Y; Moreno Lozano L; Extremera Ortega A; Galindo Bonilla PA; Alfaya Arias T; García Rodríguez R
    J Investig Allergol Clin Immunol; 2017; 27(5):328-329. PubMed ID: 29057744
    [No Abstract]   [Full Text] [Related]  

  • 16. Spontaneous regression of colonic lymphoma following infliximab and azathioprine withdrawal in patients with Crohn's disease.
    Flynn AD; Azar JM; Chiorean MV
    Inflamm Bowel Dis; 2013 Apr; 19(5):E69-70. PubMed ID: 23399737
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombophlebitis of cephalic vein in the left forearm related to infliximab infusion.
    Huang ZY; Lin L; Tang Q; Wang YF
    J Dig Dis; 2016 Nov; 17(11):773-776. PubMed ID: 27598885
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute generalized exanthematous pustulosis induced by iodixanol (Visipaque): a serious reaction to a commonly used drug.
    Ozturk U; Sungur MA; Karakas T; Mulayim K; Ozturk P
    Cutan Ocul Toxicol; 2015; 34(4):344-6. PubMed ID: 25363067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute localized exanthematous pustulosis caused by a herbal medicine, dai-kenchu-to.
    Tsutsumi R; Yoshida Y; Adachi K; Nanba E; Yamamoto O
    Contact Dermatitis; 2018 Oct; 79(4):257-259. PubMed ID: 30014493
    [No Abstract]   [Full Text] [Related]  

  • 20. Desquamating pustular rash.
    Lo KBU; Azmaiparashvili Z
    Cleve Clin J Med; 2019 Dec; 86(12):780-781. PubMed ID: 31821140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.